|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||1.31|
|PE ratio (TTM)||0.07|
|Earnings date||01 Nov 2023 - 06 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.
DALLAS, September 12, 2023--Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.